Antiretroviral therapy coverage for PMTCT in Colombia

Colombia: Antiretroviral therapy coverage for PMTCT was 53.0% in 2023. ◆ Volatile

Latest (2023)
53.0%
Change on year
down 1.9%
World rank
66th
of 84 countries
All-time high
68.0%
in 2014
All-time low
0.0%
in 2000
Years of data
24
2000–2023

Antiretroviral therapy coverage for PMTCT in Colombia, 2000–2023

02040602000201120232000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 4 % of pregnant women living with HIV2004: 12 % of pregnant women living with HIV2005: 23 % of pregnant women living with HIV2006: 11 % of pregnant women living with HIV2007: 16 % of pregnant women living with HIV2008: 33 % of pregnant women living with HIV2009: 36 % of pregnant women living with HIV2010: 47 % of pregnant women living with HIV2011: 56 % of pregnant women living with HIV2012: 58 % of pregnant women living with HIV2013: 61 % of pregnant women living with HIV2014: 68 % of pregnant women living with HIV2015: 57 % of pregnant women living with HIV2016: 60 % of pregnant women living with HIV2017: 60 % of pregnant women living with HIV2018: 56 % of pregnant women living with HIV2019: 59 % of pregnant women living with HIV2020: 58 % of pregnant women living with HIV2021: 56 % of pregnant women living with HIV2022: 54 % of pregnant women living with HIV2023: 53 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Colombia recorded 53.0% for antiretroviral therapy coverage for pmtct in 2023.

Compared with earlier readings it is down 1.9% on the previous year and down 13.1% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Colombia peaked at 68.0% in 2014 and was at its lowest, 0.0%, in 2000.

That places Colombia 66th out of 84 countries with data for 2023, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Colombia, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Colombia, 2000 to 2023.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 4.0%
2004 12.0% +200.0%
2005 23.0% +91.7%
2006 11.0% -52.2%
2007 16.0% +45.5%
2008 33.0% +106.2%
2009 36.0% +9.1%
2010 47.0% +30.6%
2011 56.0% +19.1%
2012 58.0% +3.6%
2013 61.0% +5.2%
2014 68.0% +11.5%
2015 57.0% -16.2%
2016 60.0% +5.3%
2017 60.0% +0.0%
2018 56.0% -6.7%
2019 59.0% +5.4%
2020 58.0% -1.7%
2021 56.0% -3.4%
2022 54.0% -3.6%
2023 53.0% -1.9%

Colombia compared with similar countries

  • Colombia's 53.0% is below the median for upper middle income countries, which is 79.5%, 67% of the median. (22 countries reporting)
  • Colombia's 53.0% is below the median for Latin America & Caribbean, which is 68.0%, 78% of the median. (15 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Colombia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +200.0% 4.0% 12.0%
2008 +106.2% 16.0% 33.0%
2005 +91.7% 12.0% 23.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 13.5% 0.0% 36.0% 10
2010s 58.2% 47.0% 68.0% 10
2020s 55.2% 53.0% 58.0% 4

Countries ranked near Colombia

  1. 63 Fiji 57.0% compare
  2. 64 Netherlands 55.0% compare
  3. 65 Myanmar 54.0% compare
  4. 67 Paraguay 52.0% compare
  5. 68 Mali 46.0% compare
  6. 69 Somalia 43.0% compare

See the full ranking of 99 places →

More health data for Colombia

All data for Colombia →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Colombia?
Antiretroviral therapy coverage for pmtct in Colombia was 53.0% in 2023, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Colombia?
The highest recorded value was 68.0% in 2014.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Colombia?
The lowest recorded value was 0.0% in 2000.
How does Colombia rank for antiretroviral therapy coverage for pmtct?
Colombia ranks 66th out of 84 countries with data for 2023.
Is antiretroviral therapy coverage for pmtct rising or falling in Colombia?
Over the last ten years it is down 13.1%. The long-run trend across the full record is volatile.
Where does this Colombia data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Colombia. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/colombia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/colombia/">Antiretroviral therapy coverage for PMTCT in Colombia</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).